Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Amgen | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Amgen

Enbrel sales down 6% in the quarter due to lower demand

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen
3Q Revenues: $5.8 billion (-1%)
3Q Earnings: $2.0 billion (flat)
YTD Revenues: $17.0 billion (flat)
YTD Earnings: $6.2 billion (+8%)
Comments: Enbrel sales were $1.4 billion in the quarter, down 6% due to lower unit demand. Neulasta sales decreased 6% to $1.1 billion due to lower unit demand. Aranesp sales were down 3% to $516 million driven by unfavorable changes in foreign exchange rates and lower unit demand. Prolia sales were $464 million, up 22% driven primarily by higher unit demand. Sensipar/Mimpara sales were up 10% to $457 million driven primarily by net selling price. XGEVA sales decreased 2% to $387 million driven by lower unit demand, offset partially by net selling price. EPOGEN sales were down 21% to $264 million driven primarily by unfavorable changes in net selling price and inventory. KYPROLIS sales were up 13% to $207 million driven by higher unit demand, offset partially by net selling price. Nplate sales increased 5% to $159 million driven by higher unit demand and net selling price. Vectibix sales increased 2% to $168 million driven by higher unit demand. NEUPOGEN sales were down 25% to $138 million, impacted by competition. Repatha sales increased to $89 million driven by higher unit demand. BLINCYTO sales increased 79% to $52 million driven by higher unit demand.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters